Comparison of fascaplysin and related alkaloids: A study of structures, cytotoxicities, and sources

Journal of Natural Products

Volumn 67, Issue 5, 2004, Pages 783-792

  Segraves, Nathaniel L ^a   Robinson, Sarah J ^a   Garcia, Daniel ^a   Said, Sadri A ^b   Fu, Xiong ^b   Schmitz, Francis J ^b   Pietraszkiewicz, Halina ^c   Valeriote, Frederick A ^c   Crews, Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c Josephine Ford Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

10 BROMOFASCAPLYSIN; 14 BROMORETICULATOL; 3 BROMOFASCAPLYSIN; 3 BROMOHOMOFASCAPLYSIN B; 3 BROMOHOMOFASCAPLYSIN B 1; 3 BROMOHOMOFASCAPLYSIN C; 3 BROMOSECOFASCAPLYSIN A; 3 BROMOSECOFASCAPLYSIN B; 3,10 DIBROMOFASCAPLYSIN; 7,14 DIBROMORETICULATINE; ALKALOID DERIVATIVE; FASCAPLYSIN; FASCAPLYSIN A; HOMOFASCAPLYSATE A; HOMOFASCAPLYSIN B 1; HOMOFASCAPLYSIN C; NSC 622398; NSC 660649; NSC 700409; RETICULATINE; RETICULATOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; COLON CANCER; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LUNG CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; SPONGE (PORIFERA);

ALKALOIDS; ANIMALS; DRUG SCREENING ASSAYS, ANTITUMOR; FIJI; HUMANS; HYDROCARBONS, BROMINATED; INDOLES; INDONESIA; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PORIFERA; TUMOR CELLS, CULTURED; UROCHORDATA;

DIDEMNUM; DIDEMNUM SP.; INVERTEBRATA; PORIFERA;

EID: 2542511641     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np049935+     Document Type: Article

References (52)

1. Roll, D. M.; Ireland, C. M.; Lu, H. S.; Clardy, J. J. Org. Chem. 1988, 53, 3276-3278.
2. Thorectandramine (10), a type Ib compound, was reported in ref 16 and is named after the sponge it was isolated from, Thorectandra sp.
3. Bonjouklian, R.; Smitka, T. A.; Doolin, L. E.; Molloy, R. M.; Debono, M. ; Shaffer, S. A.; Moore, R. E.; Stewart, J. B.; Patterson, G. M. L. Tetrahedron 1991, 47, 7739-7750.
4. Omura, S.; Iwai, Y.; Hirano, A.; Nakagawa, A.; Awaya, J.; Tsuchiya, H.; Takahashi, Y.; Masuma, R. J. Antibiot. 1977, 30, 275-282.
5. (b) Osada, H.; Koshino, H.; Kudo, T.; Onose, R.; Isono, K. J. Antibiot. 1992, 45, 189-194.
6. (c) McAlpine, J. B.; Karwowski, J. P.; Jackson, M.; Mullally, M. M.; Hochlowski, J. E.; Premachandran, U.; Burres, N. S. J. Antibiot. 1994, 47, 281-288.
7. (d) Cai, Y.; Fredenhagen, A.; Hug, P.; Peter, H. H. J. Antibiot. 1995, 48, 143-148.
8. (e) Cai, Y.; Fredenhagen, A.; Hug, P.; Meyer, T.; Peter, H. H. J. Antibiot. 1996, 49, 519-526.
9. Schupp, P.; Eder, C.; Proksch, P.; Wray, V.; Schneider, B.; Herderich, M.; Paul, V. J. Nat. Prod. 1999, 62, 959-962.
10. (b) Cantrell, C. L.; Groweiss, A.; Gustafson, K. R.; Boyd, M. R. Nat. Prod. Lett. 1999, 14, 39-46.
11. (c) Cantrell, C. L.; Groweiss, A.; Gustafson, K. R.; Boyd, M. R. Nat. Prod. Lett. 1999, 14, 39-46.
12. (d) Schupp, P.; Proksch, P.; Wray, V. J. Nat. Prod. 2002, 65, 295-298.
13. Carter, D. S.; Van Vranken, D. L. J. Org. Chem. 1999, 64, 8537-8545.
14. Goel, S.; Wadler, S.; Hoffman, A.; Volterra, F.; Baker, C.; Nazario, E.; Ivy, P.; Silverman, A.; Mani, S. Invest. New Drugs 2003, 21, 103-107.
15. (b) Langevin, A.; Weitman, S. D.; Kuhn, J. G.; Weintraub, S. T.; Baruchel, S.; Furman, W.; Bernstein, M.; Blaney, S.; Vietti T. J. Ped. Hematol. Oncol. 2003, 25, 526-533.
16. Dancey, J.; Sausville, E. A. Nat. Rev. Drug Discovery 2003, 2, 296-313.
17. (b) Propper, D. J.; McDonald, A. C.; Man, A.; Thavasu, P.; Balkwill, F.; Braybrooke, J. P.; Caponigro, F.; Graf, P.; Dutreix, C.; Blackie, R.; Kaye, S. B.; Ganesan, T. S.; Talbot, D. C.; Harris, A. L.; Twelves, C. J. Clin. Oncol. 2001, 19, 1485-1492.
18. (c) Sausville, E. A. Curr. Med. Chem.: Anti-Cancer Agents 2003, 3, 47-56.
19. Segraves, N. L.; Lopez, S.; Johnson, T. A.; Said, S. A.; Fu, X.; Schmitz, F. J.; Pietraszkiewicz, H.; Valeriote, F. A.; Crews, P. Tetrahedron Lett. 2003, 44, 3471-3475.
20. Jiménez, C.; Quiñoa, E.; Adamczeski, M.; Hunter, L. M.; Crews, P. J. Org. Chem. 1991, 56, 3403-3410.
21. Jiménez, C.; Quiñoa, E.; Crews, P. Tetrahedron Lett. 1991, 32, 1843-1846.
22. Fretz, H.; Ucci-Stoll, K.; Hug, P.; Schoepfer, J.; Lang, M. Helv. Chim. Acta 2001, 84, 867-873.
23. Segraves, N. L.; Crews, P. Unpublished results.
24. Schmidt, E. W.; Faulkner, D. J. Tetrahedron Lett. 1996, 37, 3951-3954.
25. Kirsch, G.; König, G. M.; Wright, A. D.; Kaminsky, R. J. Nat. Prod. 2000, 63, 825-829.
26. Charan, R. D.; McKee, T. C.; Gustafson, K. R.; Pannell, L. K.; Boyd, M. R. Tetrahedron Lett. 2002, 43, 5201-5204.
27. Foderaro, T. A.; Barrows, L. R.; Lassota, P.; Ireland, C. M. J. Org. Chem. 1997, 62, 6064-6065.
28. Thale, Z.; Crews, P. Unpublished results.
29. Kazlauskas, R.; Murphy, P. T.; Quinn, R. J.; Wells, R. J. Tetrahedron Lett. 1977, 61-64.
30. (b) See Table 4 in: Bergquist, P. R.; Wells, R. J. In Marine Natural Products; Scheuer, P. J., Ed.; Academic Press: New York, 1983; Vol. V, pp 35-42, for the correct taxonomy of this sponge.
31. Aoki, S.; Ye, Y.; Higuchi, K.; Takashima, A.; Tanaka, Y.; Kitagawa, I.; Kobayashi, M. Chem. Pharm. Bull. 2001, 49, 1372-1374.
32. Hollenbeak, K. H.; Schmitz, F. J. Lloydia 1977, 40, 479-481.
33. Tymiak, A. A.; Rinehart, K. L.; Bakus, G. J. Tetrahedron 1985, 41, 1039-1047.
34. Djura, P.; Faulkner, D. J. J. Org. Chem. 1980, 45, 735-737.
35. Okuda, R. K.; Klein, D.; Kinnel, R. B.; Li, M.; Scheuer, P. J. Pure Appl. Chem. 1982, 54, 1907-1914.
36. (b) Fusetani, N.; Asano, M.; Mutsunaga, S.; Hashimoto, K. Comput. Biochem. Physiol., B: Biochem. Mol. Biol. 1986, 85, 845-846.
37. Fattorusso, E.; Lanzotti, V.; Magno, S.; Novellino, E. J. Nat. Prod. 1985, 48, 924-927.
38. Guella, G.; Mancini, I.; Zibrowius, H.; Pietra, F. Helv. Chim. Acta 1989, 72, 1444-1450.
39. Thale, Z.; Johnson, T.; Tenney, K.; Wenzel, P. J.; Lobkovsky, E.; Clardy, J.; Media, J.; Pietraszkewicz, H.; Valeriote, F. A.; Crews, P. J. Org. Chem. 2002, 67, 9384-9391.
40. Crews, P.; Rodríguez, J.; Jaspars, M. Organic Structure Analysis; Oxford University Press: New York, 1998.
41. Sánchez, C.; Butovich, I. A.; Braña, A. F.; Rohr, J.; Méndez, C.; Salas, J. A. Chem. Biol. 2002, 9, 519-531.
42. (b) Onaka, H.; Taniguchi, S.; Igarashi, Y.; Furumai, T. Biosci. Biotechnol. Biochem. 2003, 67, 127-138.
43. Soni, R.; Muller, L.; Furet, P.; Schoepfer, J.; Stephan, C.; Zunstein-Mecker, S.; Fretz, H.; Chaudhuri, B. Biochem. Biophys. Res. Commun. 2000, 275, 877-884.
44. Hörmann, A.; Chaudhuri, B.; Fretz, H. Bioorg. Med. Chem. 2001, 9, 917-921.
45. Sperry, S.; Valeriote, F. A.; Corbett, T. H.; Crews, P. J. Nat. Prod. 1998, 61, 241-247.
46. (b) Valeriote, F. A.; Grieshaber, C. K.; Media, J.; Pietraszkewicz, H.; Hoffman, J.; Pan, M.; McLaughlin, S. J. Exp. Ther. Oncol. 2002, 2, 228-236.
47. Kinder, F. R.; Bair, K. W.; Bontempo, J.; Crews, P.; Czutchta, A. M.; Nemzek, R.; Thale, Z.; Vattay, A.; Versace, R. W.; Weltchek, S.; Wood, A.; Zabludoff, S. D.; Phillips, P. E. Proc. Am. Assoc. Cancer Res. 2000, 41, 600-601.
48. Boyd, M. R.; Paull, K. D. Drug Dev. Res. 1995, 34, 91-109.
49. Salomon, C. E.; Deerinck, T.; Ellisman, M. H.; Faulkner, D. J. Mar. Biol. 2001, 139, 313-319.
50. For a commentary on the rationale used to argue that sponge-derived secondary metabolites may or may not be produced by symbiotic microorganisms, see: Faulkner, D. J.; Harper, M. K.; Salomon, C. E.; Schmidt, E. W. Mem. Queens. Mus. 1999, 44, 167-173.
51. Bergquist, P. R. New Zeal. J. Zool. 1980, 7, 443-503.
52. Fu, X.; Schmitz, F. J.; Lee, R. H.; Papkoff, J. S.; Slate, D. L. J. Nat. Prod. 1994, 57, 1591-1594.